Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study.

Front Psychiatry · 2020 · PMC7251160 · PMID 32508691

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Results indicated a highly significant effect of time (i.e. treatment condition) in all three measures with very large effect sizes, which confirmed the expected effects of each treatment condition (CORT: Wilk's lamda = .015, F (2,11) = 368.625, p < .001, p η 2 = .985; ACTH: Wilk's lamda = .061, F (2,11) = 85.189, p < .001, p η 2 = .939; CoP: Wilk's lamda = .544, F (2,11) = 4.616, p = .035, p η 2 = .456).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.